Novel therapeutic options in the prevention of atrial fibrillation

Hellenic J Cardiol. 2018 Sep-Oct;59(5):279-280. doi: 10.1016/j.hjc.2018.12.001. Epub 2018 Dec 20.

Authors

Stefanos Archontakis¹, Skevos Sideris²

Affiliations

¹ First Cardiology Division, University of Athens, Hippokration General Hospital, 114 Vasilisis Sofias str, Athens, Greece.
² Department of Cardiology, Hippokration General Hospital, 114 Vasilisis Sofias str, Athens, Greece. Electronic address: skevos1@otenet.gr.

PMID: 30579978
DOI: 10.1016/j.hjc.2018.12.001

No abstract available

Publication types

Editorial

MeSH terms

Angiotensin Receptor Antagonists / therapeutic use*
Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
Anti-Arrhythmia Agents / therapeutic use
Atrial Fibrillation / physiopathology
Atrial Fibrillation / prevention & control*
Atrial Remodeling / physiology*
Catheter Ablation / methods*
Disease Management*
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*

Substances

Angiotensin Receptor Antagonists
Angiotensin-Converting Enzyme Inhibitors
Anti-Arrhythmia Agents
Hydroxymethylglutaryl-CoA Reductase Inhibitors